Estuary Biotherapeutics, Inc.

👥 10 employees💰 Last funded Jul 2026
Biotechnology Research🌐 estuarybio.com
Website LinkedIn
Estuary Biotherapeutics is on a mission to make ADPKD history. We’re developing targeted genetic medicines designed to treat autosomal dominant polycystic kidney disease (ADPKD) at its root cause, combining AAV gene therapy with local, direct delivery to the kidney, with the goal of moving beyond slowing disease progression toward halting or reversing disease.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Japan
1
Frequently asked questions
Who invested in Estuary Biotherapeutics, Inc.?
Estuary Biotherapeutics, Inc. has 1 investor on record on gritt.io.
When did Estuary Biotherapeutics, Inc. last raise funding?
The most recent investment in Estuary Biotherapeutics, Inc. recorded on gritt.io was in July 2026.
What industry is Estuary Biotherapeutics, Inc. in?
Estuary Biotherapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.